Sprint partners up with Techstars to launch mobile health startup accelerator
Written by Alyssa Clark
Sprint in undergoing a new project with Techstars, a startup accelerator within the mobile health industry, and announced its launch of the Sprint Mobile Health Accelerator in Kansas City. This program from Sprint will promise three months of mentoring and up to $120,000 in capital to mobile health startup companies around the nation.
Now known as a hub of companies involved with animal health, life sciences and healthcare technology, crop science and pharmaceutical industries, Kansas City seemed like a great place to kick-this-off with its private and university laboratories and community of healthcare innovation.
"Wireless innovations are helping people around the world by improving health care, empowering people with disabilities and promoting wellness," Dan Hesse, CEO of Sprint, noted in a statement.
The Wall Street Journal reports that Kevin McGinnis, vice president-Development at Sprint, is taking a leadership role in expanding and strengthening the company's work with entrepreneurial startups. He believes the Sprint Accelerator will make a vital contribution to the region's success.
"Kansas City increasingly is gaining recognition on the national level as an emerging entrepreneurial technology center," McGinnis said. "Sprint has been expanding its work with startups and other ventures that are developing intriguing innovations. The Sprint Accelerator will act as a catalyst for growth in this market."
Sprint gives M2M solutions for multiple industries such as fleet management, as well as healthcare. Sprint is banking on maintaining a 2G network over the long-term as AT&T moves to scrap 2G; most M2M devices currently rely on 2G for communications anyway. Opening business in 2007, Techstars firm has yet to spawn a billion-dollar company; Techstars recently told Dani Frankhauser of Mashable.com that is has several companies in its greenhouse that could break $1 billion very soon. Two of the possible billion-dollar superstars include Dropbox and Airbnb.
According to Frankhauser, Techstars accepts only the top one percent of applicants to its program. "We save the VC community time and make seed deals flow more efficiently for them," explained David Cohen, Techstars’ founder and CEO.
One of the selected entrepreneurs who is accepted into Techstars program has a better chance at getting in touch with a venture capital firm. Techstars also effectively and actively markets some of its startups, promoting its program in the process.
Sprint’s Accelerator is accepting applications for admission through Dec. 6th; finalists will be notified at the beginning of early January 2014, after the three-month accelerator program starts in March. More information is available to interested parties, as well as submitting applications, at sprintaccelerator.com.
About the Author
Alyssa Clark is the Editor of Healthcare Global
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”